Lee D. Fader, Ph.D.
Affiliations: | 2002 | Chemistry | McGill University, Montreal, QC, Canada |
Google:
"Lee Fader"Mean distance: 7.8 | S | N | B | C | P |
Parents
Sign in to add mentor| Youla Tsantrizos | grad student | 2002 | McGill | |
| (Design, synthesis and physicochemical properties of aromatic peptide nucleic acids.) | ||||
| Erick M. Carreira | post-doc | 2002-2004 | ETH Zürich | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dorich S, Cox JH, Burch JD, et al. (2020) Novel pyridone EP agonists featuring allylic alcohol ω-chains. Bioorganic & Medicinal Chemistry Letters. 127104 |
| Meyers K, Cogan DA, Burke J, et al. (2017) Dihydrobenzisoxazole-4-one compounds are novel selective inhibitors of aldosterone synthase (CYP11B2) with in vivo activity. Bioorganic & Medicinal Chemistry Letters |
| Fader LD, Bailey M, Beaulieu E, et al. (2016) Aligning Potency and Pharmacokinetic Properties for Pyridine-Based NCINIs. Acs Medicinal Chemistry Letters. 7: 797-801 |
| Fader L, Brault M, Desjardins J, et al. (2016) Discovery of Potent, Orally Bioavailable Inhibitors of Human Cytomegalovirus. Acs Medicinal Chemistry Letters. 7: 525-30 |
| Fader LD, Carson R, Morin S, et al. (2014) Minimizing the Contribution of Enterohepatic Recirculation to Clearance in Rat for the NCINI Class of Inhibitors of HIV. Acs Medicinal Chemistry Letters. 5: 711-6 |
| Fader LD, Malenfant E, Parisien M, et al. (2014) Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1. Acs Medicinal Chemistry Letters. 5: 422-7 |
| Fenwick C, Amad M, Bailey MD, et al. (2014) Preclinical profile of BI 224436, a novel HIV-1 non-catalytic-site integrase inhibitor. Antimicrobial Agents and Chemotherapy. 58: 3233-44 |
| Fader LD, Landry S, Goulet S, et al. (2013) Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 2: structure-activity relationships (SAR) of the C3-phenyl moiety. Bioorganic & Medicinal Chemistry Letters. 23: 3401-5 |
| Fader LD, Landry S, Morin S, et al. (2013) Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 1: addressing configurational instability through scaffold modification. Bioorganic & Medicinal Chemistry Letters. 23: 3396-400 |
| Goudreau N, Coulombe R, Faucher AM, et al. (2013) Monitoring binding of HIV-1 capsid assembly inhibitors using (19)F ligand-and (15)N protein-based NMR and X-ray crystallography: early hit validation of a benzodiazepine series. Chemmedchem. 8: 405-14 |